These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23602690)
1. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials. Dold M; Li C; Gillies D; Leucht S Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690 [TBL] [Abstract][Full Text] [Related]
2. Benzodiazepines for schizophrenia. Dold M; Li C; Tardy M; Khorsand V; Gillies D; Leucht S Cochrane Database Syst Rev; 2012 Nov; 11(11):CD006391. PubMed ID: 23152236 [TBL] [Abstract][Full Text] [Related]
3. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. Ogawa Y; Tajika A; Takeshima N; Hayasaka Y; Furukawa TA CNS Drugs; 2014 Nov; 28(11):989-1003. PubMed ID: 25160685 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trials. Kishi T; Mukai T; Matsuda Y; Moriwaki M; Iwata N J Psychiatr Res; 2013 Nov; 47(11):1557-63. PubMed ID: 23899496 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotic drugs Siafis S; Deste G; Ceraso A; Mussoni C; Vita A; Hasanagic S; Schneider-Thoma J; Papazisis G; Davis JM; Leucht S Psychol Med; 2020 Nov; 50(15):2622-2633. PubMed ID: 31625485 [TBL] [Abstract][Full Text] [Related]
6. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials. Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041 [TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials. Galling B; Roldán A; Rietschel L; Hagi K; Walyzada F; Zheng W; Cao XL; Xiang YT; Kane JM; Correll CU Expert Opin Drug Saf; 2016 May; 15(5):591-612. PubMed ID: 26967126 [TBL] [Abstract][Full Text] [Related]
8. Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials. Leucht S; Kissling W; McGrath J J Clin Psychiatry; 2004 Feb; 65(2):177-86. PubMed ID: 15003070 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Correll CU; Rummel-Kluge C; Corves C; Kane JM; Leucht S Schizophr Bull; 2009 Mar; 35(2):443-57. PubMed ID: 18417466 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials. Srisurapanont M; Suttajit S; Maneeton N; Maneeton B J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis. Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT Hum Psychopharmacol; 2016 Jul; 31(4):286-95. PubMed ID: 27302211 [TBL] [Abstract][Full Text] [Related]
12. Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis. Sakuma K; Matsunaga S; Nomura I; Okuya M; Kishi T; Iwata N Psychopharmacology (Berl); 2018 Aug; 235(8):2303-2314. PubMed ID: 29785555 [TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs and 5-HT₃ serotonin receptor antagonists as innovative antipsychotic augmentation treatments for schizophrenia. Andrade C J Clin Psychiatry; 2014 Jul; 75(7):e707-9. PubMed ID: 25093487 [TBL] [Abstract][Full Text] [Related]
14. [Optimizing the antipsychotic potency of olanzapine by augmentation--a critical review]. Zink M Psychiatr Prax; 2006 Sep; 33(6):261-8. PubMed ID: 16929455 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis. Helfer B; Samara MT; Huhn M; Klupp E; Leucht C; Zhu Y; Engel RR; Leucht S Am J Psychiatry; 2016 Sep; 173(9):876-86. PubMed ID: 27282362 [TBL] [Abstract][Full Text] [Related]
16. Low-dose lamotrigine augmentation therapy improves residual symptoms in treatment-resistant schizophrenia: a report of five cases. Ohnuma T; Takebayashi Y; Higashiyama R; Shibata N; Arai H Asia Pac Psychiatry; 2013 Dec; 5(4):336-43. PubMed ID: 24591092 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials. Andrade C; Kisely S; Monteiro I; Rao S J Psychiatr Res; 2015 Jan; 60():14-21. PubMed ID: 25306261 [TBL] [Abstract][Full Text] [Related]
18. Long-acting injectable antipsychotics for the prevention of relapse in patients with recent-onset psychotic disorders: A systematic review and meta-analysis of randomized controlled trials. Kishi T; Oya K; Iwata N Psychiatry Res; 2016 Dec; 246():750-755. PubMed ID: 27863801 [TBL] [Abstract][Full Text] [Related]
19. Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Wolkowitz OM; Pickar D Am J Psychiatry; 1991 Jun; 148(6):714-26. PubMed ID: 1674645 [TBL] [Abstract][Full Text] [Related]
20. Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis Study. Tseng PT; Chen YW; Chung W; Tu KY; Wang HY; Wu CK; Lin PY Medicine (Baltimore); 2016 Jan; 95(4):e2475. PubMed ID: 26825886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]